Transfusion use and effect on progression-free, overall survival, and quality of life in upfront treatment of advanced epithelial ovarian cancer: evaluation of the European Organization for Research and Treatment EORTC-55971 CohortLauren Shore Prescott, Ignace Vergote, Charlotte C Sun, Diane C Bodurka, Robert L Coleman
10 November 2022
Ovarian sex cord-stromal tumors: an update on clinical features, molecular changes, and managementRehab Al Harbi, Iain A McNeish, Mona El-Bahrawy
7 January 2021
Urinary diversion after pelvic exenteration for gynecologic malignanciesCarlos Martínez-Gómez, Martina Aida Angeles, Alejandra Martinez, Bernard Malavaud, Gwenael Ferron
23 November 2020
Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB–IVA: oncologic results of a prospective randomized international multicenter (Uterus-11) intergroup studySimone Marnitz, Audrey Tieko Tsunoda, Peter Martus, Marcelo Vieira, Renato Jose Affonso Junior, João Nunes, Volker Budach, Hermann Hertel, Alexander Mustea, Jalid Sehouli, Jens-Peter Scharf, Uwe Ulrich, Andreas Ebert, Iris Piwonski, Christhardt Kohler
8 December 2020
Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850)Anna Fagotti, Maria Gabriella Ferrandina, Giuseppe Vizzielli, Tina Pasciuto, Francesco Fanfani, Valerio Gallotta, Pasquale Alessandro Margariti, Vito Chiantera, Barbara Costantini, Salvatore Gueli Alletti, Francesco Cosentino, Giovanni Scambia
7 October 2020
Enhanced Recovery After Surgery (ERAS) in gynecologic oncology: an international survey of peri-operative practiceGeetu Prakash Bhandoria, Prashant Bhandarkar, Vijay Ahuja, Amita Maheshwari, Rupinder K Sekhon, Murat Gultekin, Ali Ayhan, Fuat Demirkiran, Ilker Kahramanoglu, Yee-Loi Louise Wan, Pawel Knapp, Jakub Dobroch, Andrzej Zmaczyński, Robert Jach, Gregg Nelson
4 August 2020
Manage wisely: poly (ADP-ribose) polymerase inhibitor (PARPi) treatment and adverse eventsAinhoa Madariaga, Valerie Bowering, Soha Ahrari, Amit M Oza, Stephanie Lheureux
9 April 2020
Clinical patterns and genomic profiling of recurrent ‘ultra-low risk’ endometrial cancerMarina Stasenko, Noah Feit, Simon S K Lee, Cassandra Shepherd, Robert A Soslow, Karen A Cadoo, Kaled Alektiar, Edaise M Da Silva, Ana Paula Martins Sebastião, Mario M Leitao Jr, Ginger Gardner, Pier Selenica, Nadeem R Abu-Rustum, Britta Weigelt, Jennifer J Mueller
5 May 2020
Combining novel agents with radiotherapy for gynecologic malignancies: beyond the era of cisplatinLilie L Lin, David S Lakomy, Matthew S Ning, Fiona Simpkins, Anuja Jhingran
18 March 2020
Incorporating robotic surgery into the management of ovarian cancer after neoadjuvant chemotherapyJeremie Abitbol, Walter Gotlieb, Ziggy Zeng, Agnihotram Ramanakumar, Roy Kessous, Liron Kogan, Valerie Pare-Miron, Marcelo Rombaldi, Shannon Salvador, Beste Kucukyazici, Sonya Brin, Jeffrey How, Susie Lau
9 October 2019